Understanding the risk of clinically significant pharmacokinetic-based drug–drug interactions with drugs newly approved by the US FDA – A review of recent new drug applications (2013–2016)

DRUG METABOLISM AND PHARMACOKINETICS(2018)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要